Apotex Inc., a Canadian pharmaceutical manufacturer of generic medicines, announced the launch of APO-ApixabanTM tablets, Canada's first generic alternative to Eliquis®.
Apotex's apixaban is an oral anticoagulant indicated for the prevention and treatment of harmful blood clots. Available in 2.5 mg and 5mg tablets, this product comes in multiple package sizes including 60, 180, and 500 BTL.
Anticoagulants, also known as blood thinners, are administered to patients who are at a high risk of getting blood clots, to reduce their chances of developing serious conditions such as strokes and heart attacks.